Industry's wait for social media guidance is unlikely to pay dividends

Industry's Wait for Social Media Guidance is Unlikely to Pay Dividends
Rx Compliance Report
January 18, 2011

 
While industry and the FDA may be treading carefully when it comes to social media, consumers are not, says former FDA’s Associate Commissioner for External Relations, Peter Pitts. “People are searching for healthcare information online,” he says. “They are like animals on the hunt. They go where the information scent is the strongest.”
 
According to Pitts, who heads the Center for Medicine in the Public Interest in New York, the potential in this rapidly-evolving domain is enormous. “Today, unquestionably, healthcare begins at ‘search’,” he says.
 
Nevertheless, regulations, angst about adverse events and off-label conversations, concern about correcting misinformation, and responsibility for what he calls “this new, thrilling, and chilling, and uncontrollable thing called user-generated content” has the industry largely frozen in place. “When it comes to 21st century communications, consumer empowerment is both a blessing and a curse,” says Pitts, “because you can’t control it like advertising.”
 
Read the full piece here.

Featured

Animal health and human health are inextricably linked
  May 15, 2012  
Drug Shortages and the Role of the Middle Man
 April 13, 2012  
Obamacare's Medical Mercenaries
 April 13, 2012  

Social Networks

Receive latest news & event updates
Provide email below:

Like CMPI on Facebook
Follow CMPI on Twitter
Connect with CMPI on LinkedIn
Watch our Videos on CMPI YouTube Channel
Subscribe to Receive CMPI RSS Feeds